Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JGB Management is an alternative investment firm that specializes in providing customized financing solutions to public and private companies, with a significant focus on the life sciences and healthcare sectors. Founded in 2005, the firm primarily utilizes structured credit, senior secured debt, and convertible instruments to support companies through critical clinical trials and commercialization phases. JGB is recognized for its ability to evaluate complex regulatory and clinical milestones, allowing it to provide capital to micro-cap and small-cap entities that may have limited access to traditional banking. The firm operates as a boutique hedge fund, leveraging deep sector expertise to manage risk in the volatile biotechnology market. Its investment strategy often involves flexible terms designed to minimize dilution for existing shareholders while providing the necessary runway for value-inflection points.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on JGB Management.